Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2009
06/25/2009WO2009059259A3 Detection of worsening renal disease in subjects with systemic lupus erythematosus
06/25/2009WO2009055643A3 Test strip ejection mechanism
06/25/2009WO2009053602A3 Automated cell density adjustment method for producing an analysis plate
06/25/2009WO2009052837A3 Maldi ms-based high-throughput screening method for substances inhibiting aggregation of alzheimer's amyloid beta peptides
06/25/2009WO2009050401A3 Method for analysing a metal monolith of a catalyst
06/25/2009WO2009050277A3 Edta resistant s100a12 complexes (erac)
06/25/2009WO2009043169A8 Granzyme a and granzyme b diagnostics
06/25/2009WO2009038689A4 Compositions and methods for diagnosis and treatment of type 2 diabetes
06/25/2009WO2009035600A3 Zap-70 as predictor and modulator of effector function of t cells
06/25/2009WO2009032760A3 Electrochmical sensor and method for manufacturing
06/25/2009WO2009027703A3 Identifying organ damage
06/25/2009WO2009024805A8 An enzyme detection device
06/25/2009WO2009019230A4 Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease
06/25/2009WO2008129023A3 Oligonucleotide compositions for the treatment of alzheimer's disease
06/25/2009WO2008097908A3 Methods of diagnosing and prognosing lung cancer
06/25/2009WO2007130469A3 Induction of intracellular and secreted growth inhibitors and paracrine tumor-suppressive activity by rar ligands
06/25/2009WO2006047312A3 COMPOSITIONS AND METHODS FOR MODULATING PGC-1β TO TREAT LIPID-RELATED DISEASES AND DISORDERS
06/25/2009WO2005110461A3 Leptin peptide antagonists
06/25/2009US20090165151 Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators
06/25/2009US20090164141 Multifunctional portable electronic device
06/25/2009US20090164139 Measuring Device and Method for Determination of at Least One Chemical Property in an Oil and a Data Storing Device Obtainable By Said Method
06/25/2009US20090164135 Quaternionic algebra approach to dna and rna tandem repeat detection
06/25/2009US20090164134 Blood Glucose Tracking Apparatus and Methods
06/25/2009US20090164133 Information management techniques for metabolism-related data
06/25/2009US20090164132 Methods and systems for comparing media content
06/25/2009US20090164131 Methods and systems for specifying a media content-linked population cohort
06/25/2009US20090163844 Methods for the treatment or prevention of scars and/or keloids
06/25/2009US20090163792 Analyzer for Measuring Blood Gas Parameters
06/25/2009US20090163702 siRNA targeting Myeloid cell leukemia sequence 1
06/25/2009US20090163701 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
06/25/2009US20090163594 Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
06/25/2009US20090163577 METHODS AND COMPOSITIONS FOR ANTAGONIZING ANTI-APOPTOTIC Bcl-2-FAMILY PROTEINS
06/25/2009US20090163529 Identifying therapeutic compounds based on their physical-chemical properties
06/25/2009US20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production
06/25/2009US20090163460 Diagnostics and therapeutics for early-onset menopause
06/25/2009US20090163448 Diagnosis and treatment of human dormancy-related sequellae
06/25/2009US20090163426 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs
06/25/2009US20090163422 Three-dimensional structure of the apobec 2 structure, uses thereof, and methods for treating chronic and infectious diseases
06/25/2009US20090163415 NT-proBNP, proBNP AND BNP IMMUNOASSAYS, ANTIBODIES AND STABLE STANDARD
06/25/2009US20090163414 In-vitro method for screening accessible biological markers in pathological tissues
06/25/2009US20090163406 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells
06/25/2009US20090163405 Angiogenic peptides and uses thereof
06/25/2009US20090162946 Method of preparing a nanoparticle film having metal ions incorporated
06/25/2009US20090162945 Inhibition of gasc1
06/25/2009US20090162944 Method of Measuring Biomolecular Reaction at Ultrahigh Speed
06/25/2009US20090162943 Reagents and Methods for the Detection of Transmissible Spongiform Encephalopathy
06/25/2009US20090162938 Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof
06/25/2009US20090162926 Photon reducing agents for fluorescence assays
06/25/2009US20090162917 Subtilism Carlsberg Proteins With Reduced Immunogencity
06/25/2009US20090162891 Effective Monitoring System or Anthrax, Smallpox, or Other Pathogens
06/25/2009US20090162890 Identifying therapeutic compounds based on their physical-chemical properties
06/25/2009US20090162889 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein
06/25/2009US20090162888 Sample control for correction of sample matrix effects in analytical detection methods
06/25/2009US20090162885 Systems and methods for measuring fluid properties
06/25/2009US20090162878 Methods and compositions for detecting and quantifying sappb
06/25/2009US20090162877 Methods to Identify Protein Arginine Deiminase 4 Inhibitors
06/25/2009US20090162876 Myeloperoxidase assays
06/25/2009US20090162875 Peptide diagnostic agent for lyme disease
06/25/2009US20090162874 Method for screening anticancer substances, set or kit for implementing said method
06/25/2009US20090162873 Gene encoding a multidrug-resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
06/25/2009US20090162872 Competitive receptor binding assay for detecting beta-glucans having immunomodulatory activity in a human cell
06/25/2009US20090162871 Using solid support comprising immobilized factor VII activating protease (FSAP) to detect autoantibodies against protease; fibrinolysis a nd blood clotting factors
06/25/2009US20090162870 Fatty acid synthase in liver disease
06/25/2009US20090162869 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell
06/25/2009US20090162868 Gene Markers and Utilization of the Same
06/25/2009US20090162867 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
06/25/2009US20090162865 northern blotting, electrophoresis, PCR
06/25/2009US20090162861 Method for suppressing a fret signal, fret signal suppressor agents and use in a method for multiplexing biological events
06/25/2009US20090162854 Methods and kits for diagnosis of schizophrenia
06/25/2009US20090162852 Baalc expression as a diagnostic marker for acute leukemia
06/25/2009US20090162851 Target-specific hybrid capture (TSHC) for enhanced detection of homologous nucleotide sequences; classifying microorganisms; diagnosing infection, genetic abnormality and cell proliferative disorders; rapid, sensitive, highly specific and capable of discriminating highly homologous nucleic acids
06/25/2009US20090162850 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
06/25/2009US20090162847 Rapid detection of the "high-virulent" st-17 clone of group b streptococcus
06/25/2009US20090162845 Affinity tag nucleic acid and protein compositions, and processes for using same
06/25/2009US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
06/25/2009US20090162838 Fluorescence resonance energy transfer enzyme substrates
06/25/2009US20090162833 Test device for rapid diagnostics
06/25/2009US20090162532 Method and reagent for producing narrow, homogenous reagent strips
06/25/2009US20090162432 Stable laquinimod preparations
06/25/2009US20090162381 Method for Treating Vascular Disorders
06/25/2009US20090162379 Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor
06/25/2009US20090162374 Specific removal of activated immune cells
06/25/2009US20090162371 Anti-IL-23 Antibodies, Compositions, Methods and Uses
06/25/2009US20090162369 Synthetic chimeric peptides
06/25/2009US20090162363 Pedf-r receptor and uses
06/25/2009US20090162361 Method for diagnosing pancreatic cancer
06/25/2009US20090162357 Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
06/25/2009US20090162350 Novel composition and methods for the treatment of immune related disease
06/25/2009US20090162348 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
06/25/2009US20090162338 Inhibiting metastasis of cancer cells by administering a phosphatidyl inositol 3-kinase inhibitor such as Wortmannin or LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one)
06/25/2009US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease
06/25/2009US20090162330 Method of Isolating Human Neuroepithelial Precursor Cells from Human Fetal Tissue
06/25/2009US20090162328 In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation
06/25/2009US20090162284 Anti-igf-i receptor antibody
06/25/2009US20090162283 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
06/25/2009US20090162280 Detecting soluble a-beta
06/25/2009US20090161104 Plasmon resonant particles, methods and apparatus
06/25/2009US20090160431 Measuring Method, Arrangement and Software Product
06/25/2009US20090159795 Device for the analysis of isotope ratios
06/25/2009US20090159776 Image capturing system, image capturing method, and computer readable medium